Clinical Trials Logo

Infections, Rotavirus clinical trials

View clinical trials related to Infections, Rotavirus.

Filter by:

NCT ID: NCT01592838 Completed - Clinical trials for Infections, Rotavirus

Impact on Quality of Hospital Care During Pre- and Post- Rotavirus (RV) Vaccination Introduction in Belgium

Start date: December 2013
Phase: N/A
Study type: Observational

This study aims to investigate whether a change in the pattern of hospitalisation was observed in paediatric wards over the last 6 years (June 2004 - May 2010), whether a change in staff workforce availability was observed in paediatric wards over the last 6 years (during a whole year or during specific time periods of the year) and if changes of any of the variables measured during the observation period could be linked to the introduction of rotavirus vaccination.

NCT ID: NCT01563159 Completed - Clinical trials for Infections, Rotavirus

Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011

Start date: March 31, 2015
Phase: N/A
Study type: Observational

This study aims to confirm the statistically significant decline in rotavirus related and in acute gastro-enteritis (AGE) related hospital admissions that was observed in 11 participating hospitals, after the introduction of RV vaccines in Belgium in 2006.

NCT ID: NCT01563146 Completed - Clinical trials for Infections, Rotavirus

Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007

Start date: February 1, 2016
Phase: N/A
Study type: Observational

This study aims to collect data and assess the number of rotavirus related hospitalizations in 11 hospitals in Belgium - season 2006-2007 in order to develop proper age-cohort analysis over time.

NCT ID: NCT01435967 Completed - Clinical trials for Infections, Rotavirus

Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™

Start date: September 2011
Phase: N/A
Study type: Observational

The aim of this study is to monitor any impact in the change from the lyophilised formulation to the liquid formulation of the Rotarix™ vaccine on hospitalisations for rotavirus gastroenteritis. This is planned to be assessed by comparing trends of hospitalisations due to laboratory confirmed rotavirus gastroenteritis in children <=5 years of age, before and after introduction of the liquid formulation of the vaccine in Belgium.

NCT ID: NCT01339221 Completed - Clinical trials for Infections, Rotavirus

Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium

Start date: March 2011
Phase: N/A
Study type: Observational

The main aim of this study is to investigate cases of rotavirus gastroenteritis in Belgian children with opportunity to receive Rotarix™ to monitor the potential occurrence of genetic drifts (point mutations) in the vaccine strain and the occurrence of genetic shifts (re-assortments) between vaccine and naturally circulating wild-type strains in Belgium population after the introduction of Rotarix™. The study will also detect if there is any alteration in rotavirus pathogenicity conferred by re-assortment and if the mutated vaccine strain is still efficacious in preventing rotavirus gastroenteritis.

NCT ID: NCT01253967 Completed - Clinical trials for Infections, Rotavirus

Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania

Start date: February 2008
Phase: N/A
Study type: Observational

The purpose of this hospital based study is to estimate the proportion of rotavirus gastroenteritis in children < 5 years of age in Romania.

NCT ID: NCT01198769 Completed - Clinical trials for Infections, Rotavirus

Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.

Start date: November 11, 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess immunogenicity and safety of Rotarix TM when administered in healthy Taiwanese infants (aged 6 to 12 weeks at the time of first vaccination) who received Hepatitis B immunoglobulin after birth.

NCT ID: NCT01177826 Completed - Clinical trials for Infections, Rotavirus

Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children

Start date: February 23, 2008
Phase:
Study type: Observational

The purpose of this study is to assess vaccine effectiveness of Rotarix in preventing rotavirus severe gastroenteritis among hospitalized infants, in Belgium.

NCT ID: NCT01171963 Completed - Clinical trials for Infections, Rotavirus

Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants

Start date: August 29, 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy, immunogenicity and safety of GSK Biologicals' liquid human rotavirus vaccine in healthy Chinese infants 6 to 16 weeks of age.

NCT ID: NCT01162590 Completed - Clinical trials for Infections, Rotavirus

Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults

Start date: March 1, 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety of Rotarix ™ when administered in healthy adults aged 18 to 45 years in China.